Munich, Germany

Frank Süßmeier

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bayer Aktiengesellschaft. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Süßmeier. Retrieved from https://idiyas.com/inventor/frank-süßmeier-717jy1f4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Süßmeier: Innovator in Medicinal Chemistry

Introduction

Frank Süßmeier is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on addressing vascular disorders, which are critical in modern medicine.

Latest Patents

Frank Süßmeier holds a patent for "Substituted S-alaninate derivatives." This invention relates to substituted S-alaninate derivatives and outlines processes for their preparation. Additionally, it details their use in creating medicaments aimed at treating and preventing diseases, especially vascular disorders, including thrombotic or thromboembolic complications.

Career Highlights

Süßmeier is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to engage in cutting-edge research and development, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Frank has collaborated with esteemed colleagues such as Hartmut Beck and Stefanie Mesch. These partnerships have fostered innovation and have been instrumental in the successful development of his patented technologies.

Conclusion

Frank Süßmeier exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to medicinal chemistry, particularly through his patented work, highlight the importance of research in developing effective treatments for vascular disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…